Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 671

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial

Open access
Levine, Arie, Wine, Eytan, Assa, Amit, Sigall Boneh, Rotem, Shaoul, Ron, Kori, Michal, Cohen, Shlomi, Peleg, Sarit, Shamaly, Hussein, On, Avi, Millman, Peri, Abramas, Lee, Ziv-Baran, Tomer, Grant, Shannan, Abitbol, Guila, Dunn, Katherine A., Bielawski, Joseph P., Van Limbergen, Johan·2019·Gastroenterology

Abstract

BACKGROUND & AIMS Exclusive enteral nutrition (EEN) is recommended for children with mild-to-moderate Crohn's disease (CD) but implementation is challenging. We compared EEN to the CD exclusion-diet (CDED), a whole-food diet coupled with partial enteral nutrition (PEN), designed to reduce exposure to dietary components that have adverse effects on the microbiome and intestinal barrier. METHODS We performed a 12-week prospective trial of children with mild to moderate CD. The children were randomly assigned to a group that received CDED plus 50% of calories from formula (Modulen, Nestlé) for 6 weeks (stage 1) followed by CDED with 25% PEN from weeks 7-12 (stage-2) (n=40, group 1) or a group that received EEN for 6 weeks followed by a free diet with 25% PEN from weeks 7-12 (n=38, group 2). Patients were evaluated at baseline and weeks 3, 6, and 12 and laboratory tests were performed. 16S rRNA gene (V4V5) sequencing was performed on stool samples. The primary endpoint was dietary tolerance. Secondary endpoints were intention to treat (ITT) remission at week 6 ( pediatric CD activity index score below 10) and corticosteroid-free ITT sustained remission at week 12. RESULTS Four patients withdrew from the study because of intolerance by 48 hours, 74 patients (mean age 14.2±2.7 years) were included for remission analysis. The combination of CDED and PEN was tolerated in 39 children (97.5%), whereas EEN was tolerated by 28 children (73.6%) (P=.002; odds ratio for tolerance of CDED and PEN, 13.92; 95% CI, 1.68-115.14). At week 6, 30/40 children (75%) given CDED plus PEN were in corticosteroid-free remission vs 20/34 children (59%) given EEN (P=.38). At week 12, 28/37 children (75.6%) given CDED plus PEN were in corticosteroid-free remission compared with 14/31 children (45.1%) given EEN and then PEN (P=.01; odds ratio for remission in children given CDED and PEN, 3.77; CI, 1.34-10.59). In children given CDED plus PEN, corticosteroid-free remission was associated with sustained reductions in inflammation (based on serum level of C-reactive protein and fecal level of calprotectin) and fecal Proteobacteria. CONCLUSION CDED plus PEN was better tolerated than EEN in children with mild to moderate CD. Both diets were effective in inducing remission by week 6. The combination CDED plus PEN induced sustained remission in a significantly higher proportion of patients than EEN, and produced changes in the fecal microbiome associated with remission. These data support use of CDED plus PEN to induce remission in children with CD. Clinicaltrials.gov no: NCT01728870.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2019.04.021

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 671

Metadata

Authors
Levine, A., Wine, E., Assa, A., Sigall Boneh, R., Shaoul, R., Kori, M., Cohen, S., Peleg, S., Shamaly, H., On, A., Millman, P., Abramas, L., Ziv-Baran, T., Grant, S., Abitbol, G., Dunn, K. A., Bielawski, J. P., & Van Limbergen, J.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2019-08
Volume
157
Issue
2
Pages
440-450.e8
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2948489634
Cited by
671
References
34
FWCI
40.09
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. https://app.cochat.ai/papers/10.1053/j.gastro.2019.04.021
The paper
Levine, A., Wine, E., Assa, A., Sigall Boneh, R., Shaoul, R., Kori, M., Cohen, S., Peleg, S., Shamaly, H., On, A., Millman, P., Abramas, L., Ziv-Baran, T., Grant, S., Abitbol, G., Dunn, K. A., Bielawski, J. P., & Van Limbergen, J. (2019). Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. https://doi.org/10.1053/j.gastro.2019.04.021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.